Sign In
Buy AYLA
$0.504
+0 (+0%)
At Close: Apr 17, 2023
Ayala Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
08:00am, Thursday, 02'nd Sep 2021
REHOVOT, Israel and WILMINGTON, Del., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small m
Ayala Pharmaceuticals, Inc. (AYLA) Reports Q2 Loss, Lags Revenue Estimates
10:53am, Friday, 13'th Aug 2021
Ayala Pharmaceuticals, Inc. (AYLA) delivered earnings and revenue surprises of -19.05% and -25.61%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the
Recap: Ayala Pharmaceuticals Q2 Earnings
08:49am, Friday, 13'th Aug 2021
Shares of Ayala Pharmaceuticals (NASDAQ:AYLA) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were down 1.35% over the past year to ($0.75), which missed the
Ayala Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update
08:00am, Friday, 13'th Aug 2021
- Enrolled the First Patient in the Phase 2/3 Pivotal Trial of AL102 for the Treatment of Desmoid Tumors
Will Ayala Pharmaceuticals, Inc. (AYLA) Report Negative Q2 Earnings? What You Should Know
04:44pm, Thursday, 05'th Aug 2021
Ayala Pharmaceuticals, Inc. (AYLA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AYLA Stock Increased 3.3%: Why It Happened
06:19pm, Tuesday, 13'th Jul 2021
The stock price of Ayala Pharmaceuticals Inc (NASDAQ: AYLA) increased 3.3% today. This is why it happened.
Ayala Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference
09:00am, Tuesday, 06'th Jul 2021
REHOVOT, Israel & WILMINGTON, Del., July 06, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small mole
Ayala Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
09:01am, Thursday, 27'th May 2021
REHOVOT, Israel and WILMINGTON, Del., May 27, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small mol
Ayala Pharmaceuticals, Inc. (AYLA) Reports Q1 Loss, Misses Revenue Estimates
10:32am, Friday, 14'th May 2021
Ayala Pharmaceuticals, Inc. (AYLA) delivered earnings and revenue surprises of -4.23% and -25.08%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the
Ayala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update
08:15am, Friday, 14'th May 2021
- First Patient Dosed in Phase 1 AL102 Combination Trial with Novartis' Anti-BCMA Agent for the Treatment of Multiple Myeloma -
REHOVOT, Israel and WILMINGTON, Del., April 21, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small m
Ayala Pharmaceuticals Raises $25M Via Equity To Fund AL102 Development In Connective Tissue Tumors
10:50am, Friday, 19'th Feb 2021
Ayala Pharmaceuticals Inc (NASDAQ: AYLA) will raise $25 million via a private placement of around 1.7 million units at $15 per unit from institutional investors, including Redmile Group and SIO Ca
Ayala Pharmaceuticals Announces $25 Million Strategic Financing
09:29am, Friday, 19'th Feb 2021
Funding Extends Cash Runway through Multiple Expected Value Drivers Into 2023
REHOVOT, Israel and WILMINGTON, Del., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small mo
Ayala Pharmaceuticals (AYLA) Soars: Stock Adds 13.2% in Session
09:47am, Wednesday, 20'th Jan 2021
Ayala Pharmaceuticals (AYLA) saw a big move last session, as its shares jumped more than 13% on the day, amid huge volumes.
